Clinical Trial Update: Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

View source ↗

Summary

An observational follow-up extension study of AFF002 and AFF004A in Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AFF002
• AFF004A

Snippet

Sponsor: Affiris AG | Conditions: Alzheimer´s Disease | Status: TERMINATED